Comparing Mycitracin Triple Antibiotic vs Polyfusor D
Mycitracin Triple Antibiotic (bacitracin / neomycin / polymyxin b) | Polyfusor D (lvp solution) |
|
---|
Mycitracin Triple Antibiotic (bacitracin / neomycin / polymyxin b) | Polyfusor D (lvp solution) |
|
---|---|---|
Over-the-counter
Prescribed for Bacterial Skin Infection. Mycitracin Triple Antibiotic may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Dehydration. Polyfusor D may also be used for purposes not listed in this medication guide. |
|
More about (bacitracin / neomycin / polymyxin b) | More about (lvp solution) | |
Ratings & Reviews | ||
Mycitracin Triple Antibiotic has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
|
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all Polyfusor D side effects |
||
Drug Class | ||
Generic Availability | ||
N/A |
N/A |
|
Pricing and Coupons * Prices are without insurance | ||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
Dosage Forms | ||
N/A |
N/A |
|
Brand Names | ||
Other bacitracin / neomycin / polymyxin b brands include: Curad Triple Antibiotic, Medi-Quik, Neosporin, Triple Antibiotic | Other lvp solution brands include: Delflex, Delflex A Low Ca Low Mg with 1.5% Dextrose, Delflex A Low Ca Low Mg with 2.5% Dextrose, Delflex A Low Ca Low Mg with 4.25% Dextrose, Delflex A Low Mg with 1.5% Dextrose, Delflex A Low Mg with 2.5% Dextrose, Delflex A Low Mg with 4.25% Dextrose, Delflex A with 1.5% Dextrose, Delflex A with 2.5% Dextrose, Delflex A with 4.25% Dextrose, Delflex Low Ca Low Mg with 1.5% Dextrose, Delflex Low Ca Low Mg with 2.5% Dextrose, Delflex with 0.5% Dextrose, Delflex with 1.5% Dextrose, Delflex with 2.5% Dextrose, Delflex with 4.25% Dextrose, Dextrose 2.5% and 0.45% SodiumChloride, Dextrose 3.75% and 0.225% Sodium Chloride, Dextrose 4% and 0.18% Sodium Chloride, Dextrose 5% and Plasma-Lyte 148, Dextrose 5% in 50% Hartmanns, Dextrose 5% in Lactated Ringer's Injection, Dextrose and Ringer's, Dialyte, Dianeal Low Calcium with 1.5% Dextrose, Dianeal Low Calcium with 2.5% Dextrose, Dianeal Low Calcium with 3.5% Dextrose, Dianeal Low Calcium with 4.25% Dextrose, Dianeal PD-1 with 1.5% Dextrose, Dianeal PD-1 with 2.5% Dextrose, Dianeal PD-1 with 3.5% Dextrose, Dianeal PD-1 with 4.25% Dextrose, Dianeal PD-2 with 1.5% Dextrose, Dianeal PD-2 with 2.5% Dextrose, Dianeal PD-2 with 3.5% Dextrose, Dianeal PD-2 with 4.25% Dextrose, Dianeal PD-4, Extraneal, Isolyte S, Isolyte S PH 7.4, Lacellate, Lactated Ringers Injection, Normosol-R, Normosol-R and 5% Dextrose, Normosol-R PH 7.4, Plasma-Lyte, Plasma-Lyte 148, Plasma-Lyte A PH-7.4, Ringer's and Dextrose, Ringer's Injection, Steriflex No1, Steriflex No18, Steriflex No19, Steriflex No2, Steriflex No3, Steriflex No42, Steriflex No45, Steriflex No6, Steriflex No9 View more | |
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
N/A |
N/A |
|
CSA Schedule 1 View glossary of CSA terms | ||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
Pregnancy Category | ||
Category N
Not classified
|
Category C
Risk cannot be ruled out
|
|
Drug Interactions | ||
A total of 21 drugs are known to interact with Mycitracin Triple Antibiotic:
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
Alcohol/Food/Lifestyle Interactions | ||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
Disease Interactions | ||
First Approval Date | ||
N/A |
N/A |
|
WADA Class View classifications | ||
N/A |
N/A |
|
More Information | ||
Patient Resources | ||
N/A |
N/A |
|
Professional Resources | ||
N/A |
N/A |
|
Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.